Scientists discover immune cell that 'may treat all cancer'
Researchers from Cardiff University have allegedly discovered a T-cell that raises the prospect of a "one-size-fits-all' cancer treatment".
According to a report by BBC News, researchers found that the cell and its receptor that could find and a range of cancerous cells in laboratory conditions, including lung, skin, blood, colon, breast, bone, prostate, ovarian, kidney, and cervical cancer cells.
The researchers claim that this cell could one day provide doctors with a "one-size" fits all cancer treatment.
It's so important to check yourself for any early warning signs. This TV reporter was diagnosed with breast cancer on Facebook Live:
The study, which was recently published in the scientific journal Nature Immunology, involved immunologists injecting the T-cells into lab mice with human cancers and human immune systems to test their therapeutic potential.
Commenting on his discovery, lead study author Professor Andrew Sewell, stated: "We hope this new TCR may provide us with a different route to target and destroy a wide range of cancers in all individuals. Current TCR-based therapies can only be used in a minority of patients with a minority of cancers."
He added: '[This discovery] raises the prospect of a 'one-size-fits-all' cancer treatment; a single type of T-cell that could be capable of destroying many different types of cancers across the population. Previously, nobody believed this could be possible."
Watch Joe Biden deliver an emotional speech about cancer:
Meanwhile, Daniel Davis, professor of immunology at the University of Manchester, stated: 'In general, we are in the midst of a medical revolution harnessing the power of the immune system to tackle cancer. But not everyone responds to the current therapies and there can be harmful side-effects."
He added: "The Cardiff team and their collaborators have made the exciting discovery that a type of immune cell which hasn’t been studied much before, seems able to recognize a broad range of cancers. The team have convincingly shown that, in a lab dish, this type of immune cell reacts against a range of different cancer cells."